nodes	percent_of_prediction	percent_of_DWPC	metapath
Forasartan—AGTR1—ACE Inhibitor Pathway—REN—osteoporosis	0.194	0.198	CbGpPWpGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—ACE—osteoporosis	0.121	0.124	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TUBA1B—osteoporosis	0.0841	0.0858	CbGpPWpGaD
Forasartan—AGTR1—G alpha (q) signalling events—MGLL—osteoporosis	0.0376	0.0384	CbGpPWpGaD
Forasartan—AGTR1—ACE Inhibitor Pathway—TGFB1—osteoporosis	0.0373	0.038	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.0336	0.0343	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—PTH1R—osteoporosis	0.0239	0.0244	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CALCR—osteoporosis	0.0239	0.0244	CbGpPWpGaD
Forasartan—Losartan—ACE—osteoporosis	0.0194	1	CrCbGaD
Forasartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.0187	0.0191	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0161	0.0164	CbGpPWpGaD
Forasartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoporosis	0.0147	0.015	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—IL1B—osteoporosis	0.014	0.0143	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CALCR—osteoporosis	0.0135	0.0138	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PTH1R—osteoporosis	0.0135	0.0138	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—PTH—osteoporosis	0.0125	0.0128	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CALCR—osteoporosis	0.0123	0.0125	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PTH1R—osteoporosis	0.0123	0.0125	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CNR2—osteoporosis	0.0122	0.0125	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—WNT1—osteoporosis	0.0115	0.0117	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TGFB1—osteoporosis	0.0109	0.0111	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—MGLL—osteoporosis	0.0107	0.0109	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—PTHLH—osteoporosis	0.0104	0.0106	CbGpPWpGaD
Forasartan—AGTR1—Allograft Rejection—TNF—osteoporosis	0.0102	0.0104	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—MGLL—osteoporosis	0.00974	0.00993	CbGpPWpGaD
Forasartan—AGTR1—Peptide ligand-binding receptors—POMC—osteoporosis	0.00938	0.00956	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—CALCA—osteoporosis	0.00915	0.00933	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00828	0.00845	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SOST—osteoporosis	0.00801	0.00816	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTH1R—osteoporosis	0.00724	0.00738	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CALCR—osteoporosis	0.00724	0.00738	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PTH—osteoporosis	0.00709	0.00723	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CNR2—osteoporosis	0.00691	0.00705	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PTH—osteoporosis	0.00644	0.00657	CbGpPWpGaD
Forasartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00629	0.00641	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CNR2—osteoporosis	0.00627	0.0064	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—WNT1—osteoporosis	0.0059	0.00602	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—PTHLH—osteoporosis	0.00588	0.00599	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MGLL—osteoporosis	0.00575	0.00587	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LRP5—osteoporosis	0.00561	0.00573	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LRP6—osteoporosis	0.00537	0.00548	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—PTHLH—osteoporosis	0.00534	0.00544	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—CALCA—osteoporosis	0.00517	0.00527	CbGpPWpGaD
Forasartan—AGTR1—GPCR ligand binding—POMC—osteoporosis	0.00479	0.00488	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—CALCA—osteoporosis	0.0047	0.00479	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TLN1—osteoporosis	0.00453	0.00462	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—P4HB—osteoporosis	0.00391	0.00399	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTH—osteoporosis	0.0038	0.00388	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—RAP1A—osteoporosis	0.00374	0.00381	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CNR2—osteoporosis	0.00371	0.00378	CbGpPWpGaD
Forasartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00369	0.00376	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—ADCY5—osteoporosis	0.00368	0.00375	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—NFATC1—osteoporosis	0.00365	0.00372	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—DKK1—osteoporosis	0.00362	0.00369	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—WNT1—osteoporosis	0.00348	0.00355	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGA—osteoporosis	0.00339	0.00346	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—ADCY5—osteoporosis	0.00334	0.00341	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PTHLH—osteoporosis	0.00315	0.00321	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—BMP2—osteoporosis	0.00315	0.00321	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—FGB—osteoporosis	0.00308	0.00315	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PSMA2—osteoporosis	0.00298	0.00304	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—PSMA5—osteoporosis	0.00298	0.00304	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—CALCA—osteoporosis	0.00277	0.00283	CbGpPWpGaD
Forasartan—AGTR1—GPCR downstream signaling—POMC—osteoporosis	0.00271	0.00276	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—KL—osteoporosis	0.00252	0.00257	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—POMC—osteoporosis	0.00246	0.00251	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL6R—osteoporosis	0.0024	0.00244	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ADCY5—osteoporosis	0.00197	0.00201	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—SPP1—osteoporosis	0.00191	0.00195	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IRS2—osteoporosis	0.00173	0.00176	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—LEP—osteoporosis	0.00169	0.00172	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—ESR1—osteoporosis	0.00161	0.00165	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IRS1—osteoporosis	0.00151	0.00154	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—POMC—osteoporosis	0.00145	0.00148	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL6R—osteoporosis	0.00142	0.00144	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IGF1—osteoporosis	0.0014	0.00142	CbGpPWpGaD
Forasartan—AGTR1—Signaling by GPCR—IL6—osteoporosis	0.00107	0.00109	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—MYC—osteoporosis	0.000839	0.000856	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—TGFB1—osteoporosis	0.000837	0.000854	CbGpPWpGaD
Forasartan—AGTR1—Signaling Pathways—IL6—osteoporosis	0.000631	0.000643	CbGpPWpGaD
